[Biological effect of hypertonic hydrosaline overload (Carter-Robbins test) on patients with cancer].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000311:Adrenal Glands / Q000502:physiology; D001943:Breast Neoplasms / Q000503:physiopathology / Q000652:urine; D004231:Diuresis; D005260:Female; D006801:Humans; D006982:Hypertonic Solutions; D008297:Male; D009369:Neoplasms / Q000503:physiopathology* / Q000652:urine; D009994:Osmolar Concentration; D010477:Perfusion; D010902:Pituitary Gland / Q000378:metabolism; D012004:Rectal Neoplasms / Q000503:physiopathology / Q000652:urine; D012965:Sodium Chloride; D013964:Thyroid Neoplasms / Q000503:physiopathology / Q000652:urine; D013997:Time Factors; D014667:Vasopressins / Q000378:metabolism; D014882:Water-Electrolyte Balance
D015065:17-Hydroxycorticosteroids; D006982:Hypertonic Solutions; D014667:Vasopressins; D012965:Sodium Chloride
Effets biologiques de la surcharge hydro-saline hypertonique (test de Carter-Robbins) chez des malades cancéreux.